CLINICAL_TRIALS
trial_result
· 2013-05-03
Clinical Trial Update: Safety of Estrogens in Lupus: Hormone Replacement Therapy [Phase 3]
Summary
A Phase 3 trial evaluating the safety of estrogen-based hormone replacement therapy in systemic lupus erythematosus has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Systemic Lupus Erythematosus | Phase 3 | Status: TERMINATED